Pancreatic Cancer Research

ResearcherWayne State UniversityNo recent work listed

Shadan S. Ali

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5105402676. Sources: OpenAlex.

Their work

Papers
19 (first author 6, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
19
Papers, trials and grants by year

2011: 6 papers · 2012: 4 papers · 2013: 3 papers · 2014: 3 papers · 2015: 1 paper · 2016: none · 2017: none · 2018: 2 papers

Papers 19

  1. Retraction notice to "Increased Ras GTPase activity is regulated by miRNAs that can be attenuated by CDF treatment in pancreatic cancer cells" [Cancer Lett. 31… Co-author DOI 10.1016/j.canlet.2017.11.030↗
  2. Retraction notice to "Notch-1 induces Epithelial-mesenchymal transition consistent with cancer stem cell phenotype in pancreatic cancer cells". Co-author DOI 10.1016/j.canlet.2018.03.020↗
  3. Differential Expression of MicroRNAs in Tissues and Plasma Co-exists as a Biomarker for Pancreatic Cancer. Co-author DOI 10.4172/1948-5956.1000372↗
  4. Deregulation of miR-146a expression in a mouse model of pancreatic cancer affecting EGFR signaling. Co-author DOI 10.1016/j.canlet.2014.05.013↗
  5. Pancreatic cancer stem-like cells display aggressive behavior mediated via activation of FoxQ1. Co-author DOI 10.1074/jbc.m113.532887↗
  6. Differentially expressed miRNAs in cancer-stem-like cells: markers for tumor cell aggressiveness of pancreatic cancer. First author DOI 10.1089/scd.2013.0551↗
  7. Activated K-Ras and INK4a/Arf deficiency promote aggressiveness of pancreatic cancer by induction of EMT consistent with cancer stem cell phenotype. First author DOI 10.1002/jcp.24162↗
  8. Garcinol sensitizes human pancreatic adenocarcinoma cells to gemcitabine in association with microRNA signatures. First author DOI 10.1002/mnfr.201200297↗
  9. Down-regulation of miR-221 inhibits proliferation of pancreatic cancer cells through up-regulation of PTEN, p27(kip1), p57(kip2), and PUMA. Co-author PMID 24224124↗
  10. Inactivation of Ink4a/Arf leads to deregulated expression of miRNAs in K-Ras transgenic mouse model of pancreatic cancer. Co-author DOI 10.1002/jcp.24036↗
  11. RETRACTED: Increased Ras GTPase activity is regulated by miRNAs that can be attenuated by CDF treatment in pancreatic cancer cells. Co-author DOI 10.1016/j.canlet.2012.01.013↗
  12. Metformin inhibits cell proliferation, migration and invasion by attenuating CSC function mediated by deregulating miRNAs in pancreatic cancer cells. Co-author DOI 10.1158/1940-6207.capr-11-0299↗
  13. Hypoxia-induced aggressiveness of pancreatic cancer cells is due to increased expression of VEGF, IL-6 and miR-21, which can be attenuated by CDF treatment. First author DOI 10.1371/journal.pone.0050165↗
  14. Over-expression of FoxM1 leads to epithelial-mesenchymal transition and cancer stem cell phenotype in pancreatic cancer cells. Co-author DOI 10.1002/jcb.23150↗
  15. The complexities of obesity and diabetes with the development and progression of pancreatic cancer. Co-author DOI 10.1016/j.bbcan.2010.11.003↗
  16. Notch-1 induces epithelial-mesenchymal transition consistent with cancer stem cell phenotype in pancreatic cancer cells. Co-author DOI 10.1016/j.canlet.2011.03.012↗
  17. Anti-tumor activity of a novel compound-CDF is mediated by regulating miR-21, miR-200, and PTEN in pancreatic cancer. First author DOI 10.1371/journal.pone.0017850↗
  18. Activated K-ras and INK4a/Arf deficiency cooperate during the development of pancreatic cancer by activation of Notch and NF-κB signaling pathways. Co-author DOI 10.1371/journal.pone.0020537↗
  19. Network modeling of CDF treated pancreatic cancer cells reveals a novel c-myc-p73 dependent apoptotic mechanism. First author PMID 21904657↗

Closest collaborators

The 19 strongest of 19 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Fazlul H. Sarkar · 17 shared papers, 2011–2018 · strength 0.65
  2. Bin Bao · 16 shared papers, 2011–2018 · strength 0.61
  3. Sanjeev Banerjee · 15 shared papers, 2011–2018 · strength 0.53
  4. Asfar Sohail Azmi · 10 shared papers, 2011–2018 · strength 0.35
  5. Amro Aboukameel · 7 shared papers, 2011–2018 · strength 0.30
  6. Philip A. Philip · 7 shared papers, 2011–2018 · strength 0.29
  7. Yiwei Li · 8 shared papers, 2011–2018 · strength 0.29
  8. Subhash Padhyé · 5 shared papers, 2011–2018 · strength 0.21
  9. Zhiwei Peter Wang · 5 shared papers, 2011–2018 · strength 0.19
  10. Lucio Miele · 4 shared papers, 2011–2018 · strength 0.15
  11. Murray Korc · 3 shared papers, 2011–2013 · strength 0.09
  12. Randall E. Brand · 1 shared paper, 2015 · strength 0.08
  13. Ramzi M. Mohammad · 2 shared papers, 2011–2014 · strength 0.07
  14. Mansi A. Parasramka · 1 shared paper, 2013 · strength 0.04
  15. SmitiV. Gupta · 1 shared paper, 2013 · strength 0.04
  16. Shaan Sarkar · 1 shared paper, 2013 · strength 0.04
  17. Yiwei Li · 1 shared paper, 2013 · strength 0.04
  18. Zhiwei Wang · 1 shared paper, 2011 · strength 0.03
  19. Jiankun Gao · 1 shared paper, 2011 · strength 0.02

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.